Banner
Home

White House requires Big Pharma to list drug prices on TV ads as soon as this summer Print E-mail
Written by FHI's Week in Review   
Monday, 13 May 2019 18:20
 
Berkeley Lovelace, Jr. reports for CNBC on May 8, 2019:
Pharmaceutical companies will be required to disclose the price of its prescription medicines in television commercials, the Trump administration says. The requirement is set to take effect as soon as this summer and will apply to drugs that cost more than $35 for a month's supply. High drug costs have become a rare bipartisan issue with lawmakers on both sides of the aisle demanding something be done.
Read more in the current issue of Week in Review>> https://conta.cc/2Hm2411
 
Last Updated on Monday, 13 May 2019 18:23
 
Big Tobacco Succeeds in Targeting Teens Print E-mail
Written by FHI's Week in Review   
Monday, 06 May 2019 17:56
 
Alex Bogusky ran an effective marketing campaign 20 years ago that helped "young people to see the tobacco companies as they really were" when it came to marketing cigarettes. His NY Times editorial, published 5/3/19, points out the current regulatory hole that is allowing Big Tobacco to ramp up marketing for vaping to teenagers. These marketing efforts have the potential to wipe out the significant public health progress over the past 2 decades in reducing tobacco use in teenagers. He advocates for corporate moral responsibility in the advertising industry through the "Quit Big Tobacco" campaign.
 
"Few healthcare professionals and executives who read this editorial will support Big Tobacco marketing vaping to teenagers," according to Craig Tanio, MD, MBA, a member of the executive team at Rezilir Health in Hollywood, FL. "It has been 55 years since the Surgeon General's first report on cigarettes and the facts are clear."
 
Read more in the current issue of Week in Review>> https://conta.cc/2GY71wQ
 
Last Updated on Monday, 06 May 2019 18:11
 
Can Machine Learning fix the Pharmaceutical Industry's productivity crisis? Print E-mail
Written by Abraham Heifets | LinkedIn   
Tuesday, 30 April 2019 13:29
 
Very few people would claim that we have all of the medicines we need, whether we're discussing untreated chronic diseases (e.g. Alzheimer's), neglected tropical diseases (e.g., Chagas), or re-emergent infectious diseases (e.g., antibiotic-resistant tuberculosis). Unfortunately, drug discovery is hard. Most people don't appreciate that there's a 66% failure rate before a drug candidate even gets to the clinic, and a 90% failure rate after that point, and that it's getting exponentially harder over time. Even achieving these rates requires large teams of smart, careful, dedicated, extensively-trained scientists who have spent many hundreds of millions of dollars on a wide diversity of experiments to prove - to other equally careful and skeptical scientists, regulators, insurance providers, doctors, and patients - that the new drug is safe, effective, and provides some advantage over existing standard of care. Drug hunters are not lacking in motivation, focus, expertise, drive, or skill, and yet we want better medicines faster. But what can be done?
Last Updated on Tuesday, 30 April 2019 13:32
 
Sponsor Showcase Print E-mail
Written by Sponsor   
Thursday, 18 April 2019 00:00
 
bdo-ftl hc florida-health-industry ad 1-19
Last Updated on Thursday, 18 April 2019 10:20
 


Banner
Website design, development, and hosting provided by
Netphiles